Pharma Business - September 14, 2020
R&D changes at Orion may lead to personnel reductions
The planned changes and renewal will affect the entire R&D organization, and the company will launch co-operation negotiations on this in Finland. The changes are intended to strengthen the company’s R&D portfolio and speed up the progress of research projects, it states. Launch co-operation negotiations In order to implement the planned changes and refocusing of Orion’s […]
Collaboration - June 11, 2020
Orion develops immuno-oncology drug discovery platform
Orion is developing an immuno-oncology (IO) drug discovery platform in the national research and innovation consortium Cancer IO. The national research and innovation project Cancer IO started in May as a part of Business Finland’s Personalized Health Program. The project will develop new solutions to enhance immunotherapy treatments and support the introduction of new therapies. […]
Collaboration - March 9, 2020
Nanoform and Orion collaborate
Nanoform and Orion Corporation have announced a collaboration to apply Nanoform’s CESS technology to new chemical entities. Building on an existing relationship, this collaboration will utilize Nanoform’s CESS technology to improve the bioavailability and solubility of selected early-development compounds, increasing the likelihood of drugs entering clinical development, states the companies. Many new chemical entities struggle […]
Drug Development Pharma - August 1, 2019
FDA approves Orion’s and Bayer’s darolutamide
The approval of darolutamide is based on the Phase III ARAMIS trial evaluating the efficacy and safety of darolutamide plus androgen deprivation therapy (ADT) compared to placebo plus ADT. Darolutamide Darolutamide, a non-steroidal androgen receptor inhibitor (ARi), under the brand name Nubeqa. The FDA approval is for the treatment of patients with non-metastatic castration-resistant prostate […]
Careers article - June 19, 2019
Orion – one of the most popular employers in Finland
In Universum’s student survey on ideal workplaces Orion was ranked third by natural science students. The Natural Resources Institute Finland was the student’s number one choice and the Finnish Environment Institute their second. “Third place is a great achievement and makes us very proud and happy. This is also an award for our systematic work […]
Pharma Award - January 30, 2017
Orion’s Vice President is CTO of the year
Reijo Salonen, Orion’s Senior Vice President, Pharmaceutical R&D and Reetta Kivelä, founder and CTO of Gold&Green Foods Ltd, have been selected as the CTOs of the Year 2017. The title CTO (Chief Technology Officer) of the year is awarded by The Finnish CTO Forum, a community for Chief Technology Officers, in cooperation with the technology […]
